Charles Morris

Charles Morris

Chief Tech/Sci/R&D Officer at PRELUDE THERAPEUTICS INCORPORATED
61 year
Health Technology
Consumer Services

Profile

Charles Q.
Morris
is currently a Member at The Royal College of Physicians and Chief Medical Officer at Prelude Therapeutics, Inc. starting in 2026.
Former positions include Vice President-Worldwide Clinical Research at Cephalon, Inc., Chief Development Officer & Executive VP at ImmunoGen, Inc. from 2012 to 2016, Chief Medical Officer & Executive Vice President at Allos Therapeutics, Inc. from 2010 to 2012, Chief Medical Officer at Radius Health, Inc. from 2018 to 2020, Vice President-Clinical Development Projects at AstraZeneca Pharmaceuticals LP, Chief Development Officer at Akamis Bio Ltd. from 2016 to 2018, and Chief Medical Officer at Celyad Oncology SA from 2021 to 2023.
Education includes undergraduate studies at the University of Sheffield Medical School.

Charles Morris active positions

CompaniesPositionStart
PRELUDE THERAPEUTICS INCORPORATED Chief Tech/Sci/R&D Officer 2026-04-19
Corporate Officer/Principal 2010-07-08

Former positions of Charles Morris

CompaniesPositionEnd
LAVA THERAPEUTICS N.V. Chief Tech/Sci/R&D Officer 2025-09-30
CELYAD ONCOLOGY SA Chief Tech/Sci/R&D Officer 2022-12-31
RADIUS HEALTH, INC. Chief Tech/Sci/R&D Officer 2020-12-14
Corporate Officer/Principal 2018-08-31
IMMUNOGEN, INC. Corporate Officer/Principal 2016-09-01
See the detail of Charles Morris's experience

Training of Charles Morris

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Charles Morris
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!